The Latest Breaking News from AstraZeneca

An Oxford scientist who worked on the AstraZeneca vaccine says he thinks scientists and politicians “probably killed hundreds of thousands of people” by damaging the reputation of the jab.

Professor Sir John Bell said ‘they have damaged the reputation of the vaccine in a way that echoes around the rest of the world’

Police rescue Keir Starmer from protesters; Sweden move comes as country plans to remove Omicron restrictions on Wednesday

AstraZeneca plc (NASDAQ: AZN) has granted 

The message that Pfizer was not suitable for people with allergies, especially those with a history of anaphylaxis, spread far and wide - but it is simply not true

Egypt has received four million doses of AstraZeneca’s COVID-19 vaccine from the United Kingdom, as part of the global COVAX agreement, Egypt's Health Ministry revealed. The vaccines were sent to Cairo International Airport in three batches on Thursday and Friday. Acting Health Minister Khaled Abdel-Ghaffar thanked the UK for supporting…

ICMR conducted a study on 39 individuals, of which 25 had taken both the doses of AstraZeneca COVID-19 vaccine, eight people had taken double dose of Pfizer jab, while six were unvaccinated.

The BBC radio presenter passed away due to a complication from the Covid AstraZeneca vaccine

The government is ramping up the rollout of fourth Covid-19 shots to residents in tourism-dependent regions as the nation gears up for border reopening next month.

A combination of tremelimumab and AstraZeneca Plc's (NASDAQ: AZN) Imfinzi (durvalumab) 

If history is any guide, there may be trouble ahead for shares of AstraZeneca (NASDAQ:AZN). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.